Supplemental training

  Create an account or log in to participate in this activity

Grant Support

Content development for this program was supported in part by an independent educational grant from Indivior, PLC. Additional funding comes from a collaboration with the New England High Intensity Drug Trafficking Program.

Target Audience

Physicians, Nurses, Nurse Practitioners, PAs, and their healthcare teams

Date of Release: March 23, 2026
Date of Expiration: March 22, 2029
Estimated time to complete: 1 hour

Learning Objectives

At the conclusion of this activity, participants will be better able to:

1. Consider the positive aspects of managing OUD treatment in primary care
2. Discuss the efficacy and limitations of FDA-approved medications for the treatment of OUD
3. Plan to use adaptive protocols to combat systems-level barriers impacting treatment for people with OUD
4. Articulate the value of an interprofessional team-based approach to OUD management
5. Overcome hesitancy to treating people with OUD

Accreditation

In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

Boston University Chobanian & Avedisian School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

Nursing Contact Hours: 1.0 of which 1.0 are eligible for pharmacology credit.

PAs

Boston University Chobanian & Avedisian School of Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until March 22, 2027. PAs should only claim credit commensurate with the extent of their participation.

Disclosure Policy

Boston University Chobanian & Avedisian School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University Chobanian & Avedisian School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.

In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships that faculty, planners, authors, and anyone who may be in control of content have with ineligible companies have been mitigated.

Faculty

Daniel P. Alford, MD, MPH, FACP, FASAM (Course Director)
Professor of Medicine
Associate Dean, Continuing Medical Education
Director, Clinical Addiction Research and Education (CARE) Unit
Boston University Chobanian & Avedisian School of Medicine | Boston Medical Center
dan.alford@bmc.org

Faculty member has no relevant financial relationships to disclose. Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.

Hallie Rozansky, MD
Assistant Professor of Medicine
Boston University Chobanian & Avedisian School of Medicine | Boston Medical Center
hallie.rozansky@bmc.org

Faculty member has no relevant financial relationships to disclose. Faculty member does plan on discussing unlabeled/investigational uses of a commercial product.

Testimonials

• Matthew Bair, MD, Indiana University School of Medicine, Indianapolis, IN
• Carols Dostal, MD, University of Texas Medical Branch, Galveston, TX
• Blake Fagan, MD, Mountain Area Healthcare Education Center, Asheville, NC
• Rachel Kon, MD, University of Virginia School of Medicine, Charlottesville, VA
• Annie Potter, NP, Boston University | Boston Medical Center, Boston, MA
• Audrey Provenzano, MD, Boston University | Boston Medical Center, Boston, MA

Providers of testimonials have no relevant financial relationships to disclose. They do not plan on discussing unlabeled/investigational uses of a commercial product.

Planning Committee

• Jessica Bocook, DO, Dosher Medical, Southport, NC
• Ilana Hardesty, MA, Assistant Director, Operations, CCE Office, Boston University Chobanian & Avedisian School of Medicine, Boston MA
• Delilah Dominguez, PA, Yale New Haven Psychiatric Hospital, New Haven, CT

Planning Committee members have no relevant financial relationships to disclose.

Disclaimer

THIS CONTINUING EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.